AIM-listed Ergomed is already running trials in Italy for two possible Covid-19 treatments, but these are just part of the company’s growing presence in several critical healthcare segments.
SMALL CAP SHARE IDEAS: Ergomed runs coronavirus trials
Something you may find interesting…
[recent_products per_page="4" columns="4" orderby="rand" order="rand"]